By pumping the science behind a brand, pharmaceutical companies can garner early loyalists—before a drug even hits the market.
Larry Iaquinto
Advertisement
Larry Iaquinto is president and COO of Interlink Healthcare Communications. He can be reached at liaquinto@IHCco.com.
Articles by Larry Iaquinto
Advertisement
Latest Updated Articles
A Platform for SuccessFebruary 1st 2007
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
5